Activity and tolerability of maintenance avelumab (AVE) immunotherapy after first-line platinum-based polychemotherapy in patients (pts) with locally advanced or metastatic squamous cell penile carcinoma: Initial results of PULSE study.

被引：0
|
作者：
Thiery-Vuillemin, Antoine
Tartas, Sophie
Mourey, Loic
Colomba, Emeline
Borchiellini, Delphine
Goujon, Morgan
Lefort, Felix
Topart, Delphine
Barthelemy, Philippe
Lauridant, Geraldine
Meurisse, Aurelia
Vernerey, Dewi
Massard, Vincent
机构：
[1] Ctr Hosp Reg Univ, Med Oncol, Besancon, France
[2] South Lyon Hosp Ctr, Lyon, France
[3] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France
[4] Gustave Roussy, Villejuif, France
[5] Ctr Antoine Lacassagne, Nice, France
[6] CHRU Besancon, Inst Reg Fed Canc, Oncol Med, Besancon, France
[7] Univ Bordeaux, CHU Bordeaux, Dept Med Oncol, Hop St Andre, Bordeaux, France
[8] CHU Montpellier, Montpellier, France
[9] Inst Cancerol Strasbourg Europe, Strasbourg, France
[10] Les Dentellieres, Valenciennes, France
[11] Univ Hosp, Dept Oncol, Methodol & Qual Life Unit, INSERM UMR 1098, Besancon, France
[12] UMQVC, Besancon, France
[13] Univ Hosp Besancon, Besancon, France
[14] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8
引用
收藏
页数：1
相关论文
共 50 条
  • [31] IMvigor130: A randomized, phase III study evaluating first-line (1L) atezolizumab (atezo) as monotherapy and in combination with platinum-based chemotherapy (chemo) in patients (pts) with locally advanced or metastatic urothelial carcinoma (mUC).
    Galsky, Matt D.
    Grande, Enrique
    Davis, Ian D.
    De Santis, Maria
    Arija, Jose Angel Arranz
    Kikuchi, Eiji
    Mecke, Almut
    Thastrom, Ann Christine
    Bamias, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] A phase III, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy
    Ciardiello, F.
    Bang, Y-J.
    Bendell, J.
    Cervantes, A.
    Brachmann, R.
    Zhang, K.
    Raponi, M.
    Farin, H.
    Shen, L.
    ANNALS OF ONCOLOGY, 2018, 29 : 265 - 265
  • [33] Cetuximab 1 platinum-based therapy (PBT) as a first-line treatment for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): An observational study (ENCORE)
    Le Tourneau, C.
    Ghiani, M.
    Cau, M. C.
    Depenni, R.
    Ronzino, G.
    Bonomo, P.
    Montesarchio, V.
    Leo, L.
    Schulten, J.
    Messinger, D.
    Sbrana, A.
    Ghi, M. G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] First-line cetuximab plus platinum-based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real-world observational study-ENCORE
    Le Tourneau, Christophe
    Ghiani, Massimo
    Cau, Maria Chiara
    Depenni, Roberta
    Ronzino, Graziana
    Bonomo, Pierluigi
    Montesarchio, Vincenzo
    Leo, Luigi
    Schulten, Jeltje
    Salmio, Satu
    Messinger, Diethelm
    Sbrana, Andrea
    Borcoman, Edith
    Ghi, Maria Grazia
    CANCER REPORTS, 2023, 6 (05)
  • [35] Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie A.
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Rey, Gabriel Gomez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 605 - 605
  • [36] A phase 2 randomized open-label study of ramucirumab (RAM) plus first-line platinum-based chemotherapy in patients (pts) with recurrent or advanced non-small cell lung cancer (NSCLC): Final results from squamous pts
    Thomas, S.
    Doebele, R. C.
    Spigel, D.
    Tehfe, M.
    Reck, M.
    Verma, S.
    Zimmermann, A.
    Alexandris, E.
    Lee, P.
    Bonomi, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Nomogram-based prediction of overall survival (OS) of patients (pts) with metastatic urothelial carcinoma (UC) receiving first-line platinum-based chemotherapy: retrospective international study of invasive/advanced cancer of the urothelium (RISC)
    Necchi, A.
    Sonpavde, G.
    Lo Vullo, S.
    Bamias, A.
    Crabb, S. J.
    Harshman, L.
    Bellmunt, J.
    De Giorgi, U.
    Sternberg, C.
    Ladoire, S.
    Wong, Y-N.
    Yu, E. Y.
    Chowdhury, S.
    Niegisch, G.
    Srinivas, S.
    Vaishampayan, U.
    Pal, S. K.
    Rosenberg, J.
    Mariani, L.
    Galsky, M. D.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] A phase 3, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy.
    Ciardiello, Fortunato
    Bang, Yung-Jue
    Bendell, Johanna C.
    Cervantes, Andres
    Brachmann, Rainer Karl
    Zhang, Yuting
    Raponi, Mitch
    Farin, Heinrich
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial
    Guo, Ye
    Shi, Mei
    Yang, Ankui
    Feng, Jifeng
    Zhu, Xiaodong
    Choi, Young-Jin
    Hu, Guoqin
    Pan, Jianji
    Hu, Chunhong
    Luo, Rongcheng
    Zhang, Yiping
    Zhou, Liang
    Cheng, Ying
    Luepfert, Christian
    Cai, Junliang
    Shi, yuankai
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (08): : 1081 - 1087
  • [40] SAFETY OUTCOMES OF OLAPARIB AS MAINTENANCE THERAPY FOLLOWING FIRST-LINE PLATINUM-BASED CHEMOTHERAPY FOR PATIENTS WITH BRCA-MUTATED METASTATIC PANCREATIC CANCER: RESULTS FROM THE POLO STUDY
    Van Kuiken, Katelyn
    Golan, Talia
    Cui, Karen
    Brickel, Neil
    Gupta, Charu
    Kindler, Hedy
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : E61 - E62
12345